A subscription to JoVE is required to view this content. Sign in or start your free trial.
This protocol describes a method for the isolation of urinary extracellular vesicles, uEVs, from healthy human donors and their phenotypic characterization by the size and surface marker expression using flow cytometry.
Extracellular vesicles, EVs, are a heterogeneous complex of lipidic membranes, secreted by any cell type, in any fluid such as urine. EVs can be of different sizes ranging from 40-100 nm in diameter such as in exosomes to 100-1000 nm in microvesicles. They can also contain different molecules that can be used as biomarkers for the prognosis and diagnosis of many diseases. Many techniques have been developed to characterize these vesicles. One of these is flow cytometry. However, there are no existing reports to show how to quantify the concentration of EVs and differentiate them by size, along with biomarker detection. This work aims to describe a procedure for the isolation, quantification, and phenotypification of urinary extracellular vesicles, uEVs, using a conventional cytometer for the analysis without any modification to its configuration. The method's limitations include staining a maximum of four different biomarkers per sample. The method is also limited by the amount of EVs available in the sample. Despite these limitations, with this protocol and its subsequent analysis, we can obtain more information on the enrichment of EVs markers and the abundance of these vesicles present in urine samples, in diseases involving kidney and brain damage.
In mammals, blood is filtered by passing through the kidneys 250 - 300 times; during this time, urine is formed. Production of this biofluid is the result of a series of processes, including glomerular filtration, tubular reabsorption, and secretion. Metabolic waste products and electrolytes are the main components of urine. Also, other byproducts such as peptides, functional proteins, and extracellular vesicles (EVs) are excreted1,2,3,4,5,6. Initially, urinary extracellul....
The human urine samples were obtained from healthy volunteers who had signed donor-informed consent. These procedures were also approved by the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Research Ethics Committee.
1. Isolation of urinary extracellular vesicles
NOTE: The isolation protocol of uEVs is modified from ref.19. Figure 1 depicts the representation of the protocol to .......
There are several checkpoints through the protocol, and before the staining of uEVs. Therefore, it is essential to first verify the amount of protein present in the extract of uEVs. All the research groups that work with extracellular vesicles quantify the protein, as indicated in step 2.1. Supplementary Figure 2 shows a representative 96 well plate containing uEVs fraction in wells 4E, 5E, and 6E. Wells 1A, 2A, and 3A consist of blanks, but if there are no uEVs purified, the wells will take similar colo.......
Nowadays, the use of extracellular vesicles as biomarkers for several diseases has augmented, especially for those that can be isolated from non-invasive sources such as urine5,21,22,23,24. It has been proved that the isolation of uEVs is a vital resource to know the status of a healthy individual, and the diagnosis/prognosis of patients suffering several dise.......
This work was supported by grants from CONACyT (A3-S-36875) and UNAM-DGAPA-PAPIIT Program (IN213020 and IA202318). NH-I was supported by fellowship 587790 from CONACyT.
The authors want to thank Leopoldo Flores-Romo†, Vianney Ortiz-Navarrete, Antony Boucard Jr and Diana Gómez-Martin for their valuable advice for the realization of this protocol, and to all the healthy individuals for their urine samples.
....Name | Company | Catalog Number | Comments |
APC anti human CD156c (ADAM10) antibody | BioLegend | 352706 | Add 5 µL to the 20 µL of uEVs in PBS |
APC anti human TSPAN33 (BAAM) antibody | BioLegend | 395406 | Add 5 µL to the 20 µL of uEVs in PBS |
Avanti centrifuge with JA-25.5O fixed angle rotor | Beckamn Coulter | J-26S XPI | |
BD Accuri C6 Flow Cytometer | BD Biosciences | ||
β-mercaptoethanol | SIGMA-Aldrich | M3148 | |
Benchtop centrifuge with A-4-44 rotor | Eppendorf | 5804 | |
BLUEstain 2 protein ladder | GOLDBIO | P008 | |
CD9 (C-4) mouse monoclonal antibody | Santa Cruz Biotechnology | sc-13118 | |
CD63 (MX-49.129.5) mouse monoclonal antibody | Santa Cruz Biotechnology | sc-5275 | |
Cell Trace CFSE cell proliferation kit for flow cytometry | Thermo Scientific | C34554 | |
Chemidoc XRS+ system | BIORAD | 5837 | |
FITC anti human CD9 antibody | BioLegend | 312104 | Add 5 µL to the 20 µL of uEVs in PBS |
FITC anti human CD37 antibody | BioLegend | 356304 | Add 5 µL to the 20 µL of uEVs in PBS |
Fluorescent yellow particles | Spherotech | FP-0252-2 | |
Fluorescent yellow particles | Spherotech | FP-0552-2 | |
Fluorescent yellow particles | Spherotech | FP-1552-2 | |
FlowJo Software | Becton, Dickinson and Company | ||
Goat anti-mouse immunoglobulins/HRP | Dako | P0447 | |
Halt protease inhibitor cocktail | Thermo Scientific | 78429 | |
Immun-Blot PVDF membrane 0.22µm | BIORAD | 1620177 | |
Megamix-Plus FSC beads | COSMO BIO CO.LTD | 7802 | |
NuPAGE LDS sample buffer 4X | Thermo Scientific | NP0007 | |
Optima ultracentrifuge with rotor 90Ti fixed angle 355530 | Beckamn Coulter | XPN100 | |
Page Blue protein staining solution | Thermo Scientific | 24620 | |
PE anti human CD53 antibody | BioLegend | 325406 | Add 5 µL to the 20 µL of uEVs in PBS |
Pierce BCA Protein assay kit | Thermo Scientific | 23227 | |
Pierce RIPA buffer | Thermo Scientific | 89900 | |
Polycarbonate thick wall centrifuge tubes | Beckamn Coulter | 355630 | |
Spherotech 8-Peak validation beads (FL1-FL3) | BD Accuri | 653144 | |
Spherotech 6-Peak validation beads (FL4) | BD Accuri | 653145 | |
Sucrose | SIGMA-Aldrich | 59378 | |
Triethanolamine | SIGMA-Aldrich | 90279 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved